These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18024821)

  • 41. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
    Avery RL; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ
    Ophthalmology; 2006 Mar; 113(3):363-372.e5. PubMed ID: 16458968
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration.
    Joeres S; Kaplowitz K; Brubaker JW; Updike PG; Collins AT; Walsh AC; Romano PW; Sadda SR
    Ophthalmology; 2008 Feb; 115(2):347-354.e2. PubMed ID: 17628685
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of choroidal neovascularization using intravitreal bevacizumab.
    Pedersen R; Soliman W; Lund-Andersen H; Larsen M
    Acta Ophthalmol Scand; 2007 Aug; 85(5):526-33. PubMed ID: 17511757
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravitreal bevacizumab therapy for choroidal neovascularization secondary to age-related macular degeneration: 6-month results of an open-label uncontrolled clinical study.
    Giansanti F; Virgili G; Bini A; Rapizzi E; Giacomelli G; Donati MC; Verdina T; Menchini U
    Eur J Ophthalmol; 2007; 17(2):230-7. PubMed ID: 17415697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravitreal bevacizumab (Avastin) in treatment of neovascular age-related macular degeneration.
    Lazić R; Gabrić N; Dekaris I; Sarić B; Gavrić M
    Coll Antropol; 2007 Jan; 31 Suppl 1():77-81. PubMed ID: 17469757
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The as-needed treatment strategy for choroidal neovascularization: a feedback-based treatment system.
    Spaide RF
    Am J Ophthalmol; 2009 Jul; 148(1):1-3. PubMed ID: 19540983
    [No Abstract]   [Full Text] [Related]  

  • 47. Rapid progression of subclinical age-related macular degeneration in the untreated fellow eye after intravitreal bevacizumab.
    Yoon YH; Kim JG; Chung H; Lee SY
    Acta Ophthalmol; 2009 Sep; 87(6):685-7. PubMed ID: 18705680
    [No Abstract]   [Full Text] [Related]  

  • 48. Photodynamic therapy with verteporfin combined with intravitreal injection of bevacizumab for exudative age-related macular degeneration.
    Aggio FB; Melo GB; Höfling-Lima AL; Eid Farah M
    Acta Ophthalmol Scand; 2006 Dec; 84(6):831-3. PubMed ID: 17083553
    [No Abstract]   [Full Text] [Related]  

  • 49. Bevacizumab for occult subfoveal neovascularization in age-related macular degeneration.
    Jonas JB; Harder B; Spandau UH; Kamppeter BA; Libondi T; Sauder G
    Eur J Ophthalmol; 2006; 16(5):774-5. PubMed ID: 17061237
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhage.
    Stifter E; Michels S; Prager F; Georgopoulos M; Polak K; Hirn C; Schmidt-Erfurth U
    Am J Ophthalmol; 2007 Dec; 144(6):886-892. PubMed ID: 17916314
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration.
    Ahmadieh H; Taei R; Soheilian M; Riazi-Esfahani M; Karkhaneh R; Lashay A; Azarmina M; Dehghan MH; Moradian S
    BMC Ophthalmol; 2007 Jun; 7():10. PubMed ID: 17555600
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravitreal bevacizumab for myopic choroidal neovascularization.
    Rensch F; Spandau UH; Schlichtenbrede F; von Baltz S; Libondi T; Jonas JB; Vossmerbaeumer U
    Ophthalmic Surg Lasers Imaging; 2008; 39(3):182-5. PubMed ID: 18556936
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravitreal use of bevacizumab (Avastin) for choroidal neovascularization due to ARMD: a preliminary multifocal-ERG and OCT study. Multifocal-ERG after use of bevacizumab in ARMD.
    Moschos MM; Brouzas D; Apostolopoulos M; Koutsandrea C; Loukianou E; Moschos M
    Doc Ophthalmol; 2007 Jan; 114(1):37-44. PubMed ID: 17216267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intravitreal bevacizumab for refractory choroidal neovascularization (CNV) secondary to uveitis.
    Tran TH; Fardeau C; Terrada C; Ducos De Lahitte G; Bodaghi B; Lehoang P
    Graefes Arch Clin Exp Ophthalmol; 2008 Dec; 246(12):1685-92. PubMed ID: 18682970
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correspondence.
    Uparkar M; Maiti A; Natarajan S
    Retina; 2008 Mar; 28(3):527; author reply 527-8. PubMed ID: 18327151
    [No Abstract]   [Full Text] [Related]  

  • 56. [Bevacizumab (Avastin) in treatment of choroidal neovascularization secondary to age-related macular degeneration: a case report].
    Arantes TE; Nascimento VP; Maia OO; Takahashi WY
    Arq Bras Oftalmol; 2007; 70(6):1016-20. PubMed ID: 18235918
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration in treatment-naive patients.
    Pedersen KB; Sjølie AK; Møller F
    Acta Ophthalmol; 2009 Nov; 87(7):714-9. PubMed ID: 19094171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Three-monthly intravitreal bevacizumab injections for neovascular age-related macular degeneration: short-term visual acuity results.
    Ferraz D; Bressanim G; Takahashi B; Pelayes D; Takahashi W
    Eur J Ophthalmol; 2010; 20(4):740-4. PubMed ID: 20155704
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Retinal pigment epithelial tear following intravitreal injection of bevacizumab (Avastin).
    Nicolò M; Ghiglione D; Calabria G
    Eur J Ophthalmol; 2006; 16(5):770-3. PubMed ID: 17061236
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravitreal bevacizumab for choroidal neovascular membrane associated with Best's vitelliform dystrophy.
    Rishi E; Rishi P; Mahajan S
    Indian J Ophthalmol; 2010; 58(2):160-2. PubMed ID: 20195045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.